Gelangin Flex aerosol 0.2%, 40ml
Expiration Date: 05/2027
Russian Pharmacy name:
Гелангин Флекс аэрозоль 0,2%, 40мл
As a symptomatic remedy.
Symptomatic treatment for inflammatory and infectious diseases of the oral cavity and larynx:
tonsillitis, tonsillitis (including Plaut-Vincent tonsillitis, tonsillitis of the lateral ridges), pharyngitis, gingivitis, stomatitis, glossitis, periodontal disease;
fungal diseases; prevention of infectious complications before and after surgical interventions in the oral cavity and larynx and in trauma, incl. prevention of infection of the alveoli after tooth extraction;
oral hygiene, incl. and to eliminate bad breath.
Locally.
Children from 3 to 6 years old: the use of the drug is possible after consultation with a healthcare professional.
Adults and children over 6 years old: treat the affected areas while holding their breath, 1 injection for 1-2 seconds, 2 times a day.
Hexetidine adheres to the mucous membrane and therefore gives a lasting effect. In this regard, the drug should be used after meals.
Active substance:
Hexetidine 2.0 mg
Excipients:
Propylene glycol 100.0 mg, ethanol 95% (in terms of anhydrous) 43.33 mg, polysorbate 20 10.0 mg, sodium calcium edetate anhydrous 1.0 mg, levomenthol 0.7 mg, citric acid anhydrous 0.64 mg, sodium saccharinate 0.6 mg, eucalyptol 0.2 mg, 1 M sodium hydroxide solution up to pH 4.0-7.0, nitrogen up to 5 bar, water for injection up to 1.0 ml
Hypersensitivity to any component of the drug;
erosive-desquamous lesions of the oral mucosa
children up to age 3 years.
Pharmacological properties
Pharmacodynamics The
antimicrobial effect of the drug is associated with the suppression of oxidative reactions of bacterial metabolism (thiamine antagonist). The drug has a wide spectrum of antibacterial and antifungal action, in particular against gram-positive bacteria and fungi of the genus Candida. Hexetidine has a weak anesthetic effect on the mucous membrane.
The drug has an antiviral effect against influenza A viruses, respiratory syncytial virus (PC virus), herpes simplex virus type 1, affecting the respiratory tract.
Pharmacokinetics
Hexetidine adheres very well to the mucous membrane and is practically not absorbed. After a single application of the active substance, its traces are found on the gingival mucosa for 65 hours. In dental plaque, active concentrations remain for 10-14 hours after application.
Side effect
Immune system disorders
Very rare: hypersensitivity reactions (including urticaria), angioedema.
Nervous system disorders
Very rare: ageusia, dysgeusia.
Violations of the respiratory system, chest and mediastinal organs
Very rarely: cough, shortness of breath due to the appearance of a hypersensitivity reaction.
Gastrointestinal disorders
Very rare: dry mouth, dysphagia, nausea, enlarged salivary glands, vomiting.
General disorders and disorders at the injection site
Very rare: reactions at the site of application (including irritation of the oral mucosa and pharynx, burning sensation, paresthesia of the oral cavity, discoloration of the tongue, discoloration of the teeth, inflammation, blistering and ulceration).
If any of the side effects indicated in the instructions are aggravated or you notice other side effects, it is recommended to consult a doctor.
Overdose
It is unlikely that hexetidine can have toxic effects when used according to the instructions for use of the medicinal product.
Swallowing a large amount of a preparation containing ethanol may lead to signs / symptoms of alcohol intoxication.
In any case of overdose, consult your doctor immediately. Treatment is symptomatic, as with alcohol intoxication.
Gastric lavage is necessary within 2 hours after swallowing the excess dose.
Interaction with other medicinal products
No data available.
special instructions
There are no special prescriptions.
Children can use the drug from an age when there is no danger of uncontrolled swallowing or when they do not resist a foreign object (spray nozzle) in their mouth when using the aerosol and are able to hold their breath when injecting the drug. The ethanol content in the preparation is 5.15%.